Translate
Medicus Pharma Ltd.
About
Medicus Pharma Ltd. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 17 2026
Medicus Pharma Submits Orphan Drug Designation Application to U.S. FDA for SkinJect® in Gorlin Syndrome
Apr 15 2026
Medicus Pharma to Present New Teverelix Data at AACE 2026 Demonstrating Long-Acting Hormone Suppression
Apr 7 2026
New to The Street Signs Medicus Pharma Ltd. (NASDAQ:MDCX) to Transformational 12-Part National Media Series Highlighting SkinJect(TM) and Teverelix(R) Platforms
Apr 6 2026
Medicus Pharma Submits Optimized Phase 2 Study Protocol to U.S. FDA for Teverelix in Acute Urinary Retention
Apr 1 2026
Medicus Pharma Ltd Clarifies Positive SkinJect Phase 2 Dataset